Mesa Labs (NASDAQ: MLAB) director adds 2,784 shares from RSUs
Rhea-AI Filing Summary
Mesa Laboratories director Jennifer Sadie Alltoft reported the vesting and settlement of 2,784 Restricted Stock Units (RSUs) into common stock of Mesa Laboratories Inc. Each RSU represented one share of common stock and vested on August 15, 2026. On that date, 2,784 RSUs were exercised and disposed of as derivatives, and 2,784 shares of common stock were acquired at a stated price of $0.00 per share. Following these transactions, Alltoft directly held 7,662 shares of common stock and had no remaining holdings in the reported RSU award. The filing’s Rule 10b5-1 checkbox was not marked as being under a trading plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 2,784 shares
Net Buy
2 txns
Insider
Alltoft Jennifer Sadie
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units - 9 F1, F2, F3 | 2,784 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,784 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units - 9 — 0 shares (Direct);
Common Stock — 7,662 shares (Direct)
Footnotes (3)
- F1. Each RSU represents a contingent right to receive one share of the Issuer's common stock
- F2. RSUs that vested on August 15, 2026
- F3. Not Applicable
Key Figures
RSUs exercised/converted: 2,784 shares
Common shares acquired: 2,784 shares
Post-transaction common holdings: 7,662 shares
+3 more
6 metrics
RSUs exercised/converted
2,784 shares
Restricted Stock Units converted into Mesa Laboratories common stock on August 15, 2026
Common shares acquired
2,784 shares
Common stock received from RSU settlement on August 15, 2026
Post-transaction common holdings
7,662 shares
Direct common stock holdings of Jennifer Sadie Alltoft after the reported transactions
RSU-to-share ratio
1 RSU : 1 share
Each RSU represents a contingent right to receive one share of common stock
Transaction price per share
$0.00
Stated per-share price for common stock acquired in RSU conversion
Transaction date
August 15, 2026
Vesting and settlement date for the reported RSUs and related share acquisition
Key Terms
Restricted Stock Units, derivative security, Rule 10b5-1, contingent right
4 terms
Restricted Stock Units financial
"Each RSU represents a contingent right to receive one share of the Issuer's common stock"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative security financial
"transaction_action: derivative exercise/conversion for the RSU derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Rule 10b5-1 regulatory
"The filing’s Rule 10b5-1 checkbox was not marked as being under a trading plan"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
contingent right financial
"Each RSU represents a contingent right to receive one share of the Issuer's common stock"
FAQ
What insider transaction did MLAB director Jennifer Sadie Alltoft report on August 15, 2026?
Jennifer Sadie Alltoft reported vesting and settlement of 2,784 RSUs into Mesa Laboratories common stock on August 15, 2026. The derivative RSUs were exercised and converted into 2,784 common shares in a non-cash transaction at a stated price of $0.00 per share.
How many Mesa Laboratories (MLAB) RSUs vested for Jennifer Sadie Alltoft?
A total of 2,784 Restricted Stock Units (RSUs) vested for Jennifer Sadie Alltoft. Each RSU represented a contingent right to receive one share of Mesa Laboratories common stock and vested on August 15, 2026, triggering the reported exercise and conversion.
Was the August 15, 2026 MLAB insider transaction under a Rule 10b5-1 trading plan?
The filing indicates the Rule 10b5-1 checkbox was not affirmed for these transactions. This means the reported RSU vesting and share acquisition on August 15, 2026 were not designated in the form as executed pursuant to a Rule 10b5-1 trading plan.
What type of securities did MLAB director Jennifer Sadie Alltoft exercise on August 15, 2026?
Jennifer Sadie Alltoft exercised 2,784 Restricted Stock Units (RSUs), reported as a derivative security titled “Restricted Stock Units - 9.” These RSUs each converted into one share of Mesa Laboratories common stock upon vesting and settlement on August 15, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
